KRISTALOSE
Total Payments
$520,343
Transactions
5,044
Doctors
2,302
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $156,906 | 1,189 | 795 |
| 2023 | $173,718 | 1,335 | 851 |
| 2022 | $168,646 | 1,243 | 742 |
| 2021 | $21,073 | 1,277 | 728 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $414,138 | 82 | 79.6% |
| Food and Beverage | $106,184 | 4,940 | 20.4% |
| Education | $21.00 | 22 | 0.0% |
Ad
Manufacturing Companies
- Cumberland Pharmaceuticals, Inc. $520,343
Product Information
- Type Drug
- Total Payments $520,343
- Total Doctors 2,302
- Transactions 5,044
About KRISTALOSE
KRISTALOSE is a drug associated with $520,343 in payments to 2,302 healthcare providers, recorded across 5,044 transactions in the CMS Open Payments database. The primary manufacturer is Cumberland Pharmaceuticals, Inc..
Payment data is available from 2021 to 2024. In 2024, $156,906 was paid across 1,189 transactions to 795 doctors.
The most common payment nature for KRISTALOSE is "Consulting Fee" ($414,138, 79.6% of total).